Literature DB >> 24644099

Effects of a 1-year exercise and lifestyle intervention on irisin, adipokines, and inflammatory markers in obese children.

Susann Blüher1, Grigorios Panagiotou, David Petroff, Jana Markert, Antje Wagner, Thorsten Klemm, Andreas Filippaios, Alexandra Keller, Christos S Mantzoros.   

Abstract

OBJECTIVE: Exercise improves weight status and metabolism. Irisin, a novel myokine, may be involved in the regulation of metabolic function. The effect of an exercise and dietary lifestyle intervention for 1-year on irisin, adipokines (leptin, adiponectin, resistin) and inflammatory markers (C-reactive protein (CRP), soluble tumor necrosis factor receptor II (sTNFR-II) was evaluated, and predictors of irisin levels were characterized in obese children.
METHODS: Parameters were assessed at baseline and at follow-up for 65 obese children who completed the program (7-18 years, 54%boys). Their relation to weight status and metabolic risk was analyzed.
RESULTS: Anthropometric and metabolic parameters improved after completion of the program. Circulating irisin levels at baseline were 111.0 ± 8.0 ng ml(-1) and increased after the intervention by 12% [6%, 17%], P = 0.00003. There was no evidence for differences in irisin levels between genders and across age. Moreover, changes in irisin did not correlate with those in BMI-SDS, adipokines or inflammatory markers. Leptin decreased after the intervention (Δ5.3 ng ml(-1) , [3.2, 6.3], P = 10(-7) ). Anthropometric measures were significantly associated with leptin and inflammatory markers.
CONCLUSIONS: A 1-year long lifestyle intervention program is associated with improvement in anthropometric and metabolic parameters and leads to an elevation in irisin levels in obese children.
Copyright © 2014 The Obesity Society.

Entities:  

Keywords:  KLAKS program; adipocytokines; childhood obesity; irisin; metabolic syndrome

Mesh:

Substances:

Year:  2014        PMID: 24644099     DOI: 10.1002/oby.20739

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  36 in total

1.  Circulating irisin, omentin-1, and lipoprotein subparticles in adults at higher cardiovascular risk.

Authors:  Grigorios Panagiotou; Lin Mu; Brian Na; Kenneth J Mukamal; Christos S Mantzoros
Journal:  Metabolism       Date:  2014-06-09       Impact factor: 8.694

2.  Impacts of rat hindlimb Fndc5/irisin overexpression on muscle and adipose tissue metabolism.

Authors:  W Farrash; M Brook; H Crossland; B E Phillips; J Cegielski; D J Wilkinson; D Constantin-Teodosiu; P L Greenhaff; K Smith; M Cleasby; P J Atherton
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-05-05       Impact factor: 4.310

Review 3.  Physiology and role of irisin in glucose homeostasis.

Authors:  Nikolaos Perakakis; Georgios A Triantafyllou; José Manuel Fernández-Real; Joo Young Huh; Kyung Hee Park; Jochen Seufert; Christos S Mantzoros
Journal:  Nat Rev Endocrinol       Date:  2017-02-17       Impact factor: 43.330

4.  Differential Effects of Oral and Intravenous Lipid Administration on Key Molecules Related to Energy Homeostasis.

Authors:  Maria T Vamvini; Ole-Petter Hamnvik; Ayse Sahin-Efe; Anna Gavrieli; Fadime Dincer; Olivia M Farr; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2016-03-10       Impact factor: 5.958

Review 5.  Bone-adiposity cross-talk: implications for pediatric obesity. A narrative review of literature.

Authors:  Elodie Chaplais; David Thivel; David Greene; Frederic Dutheil; Pascale Duche; Geraldine Naughton; Daniel Courteix
Journal:  J Bone Miner Metab       Date:  2015-03-22       Impact factor: 2.626

6.  Association of serum irisin concentrations with the presence and severity of obstructive sleep apnea syndrome.

Authors:  Yanli Li; Xueqin Li; Dejun Sun; Shaoxi Cai
Journal:  J Clin Lab Anal       Date:  2016-10-11       Impact factor: 2.352

Review 7.  Exercise Outcomes in Childhood Obesity-Related Inflammation and Oxidative Status.

Authors:  Brisamar Estébanez; Chun-Jung Huang; Marta Rivera-Viloria; Javier González-Gallego; María J Cuevas
Journal:  Front Nutr       Date:  2022-07-04

8.  Circulating Irisin in Children and Adolescents With Prader-Willi Syndrome: Relation With Glucose Metabolism.

Authors:  Stefania Mai; Danilo Fintini; Chiara Mele; Alessio Convertino; Sarah Bocchini; Graziano Grugni; Gianluca Aimaretti; Roberta Vietti; Massimo Scacchi; Antonino Crinò; Paolo Marzullo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-14       Impact factor: 6.055

9.  Leptin administration in physiological or pharmacological doses does not alter circulating irisin levels in humans.

Authors:  A Gavrieli; G Panagiotou; C S Mantzoros
Journal:  Int J Obes (Lond)       Date:  2016-05-20       Impact factor: 5.095

10.  Factors associated with circulating concentrations of irisin in the general population cohort of the ABCD study.

Authors:  S Buscemi; D Corleo; S Vasto; C Buscemi; M F Massenti; D Nuzzo; G Lucisano; A M Barile; G Rosafio; V Maniaci; C Giordano
Journal:  Int J Obes (Lond)       Date:  2017-10-13       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.